Biocept (BIOC) Reports Q2 Loss of $0.22

Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.22), versus ($0.67) reported last year. Revenue for the quarter came in at $76.77 million, versus $19.25 million reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c